Scarica l'app Stockscreener
106.45
1.34%
1.41
Dopo l'orario di chiusura:
106.20
-0.25
-0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$105.04
Aprire:
$105.365
Volume 24 ore:
5.34M
Relative Volume:
0.38
Capitalizzazione di mercato:
$264.21B
Reddito:
$63.90B
Utile/perdita netta:
$19.05B
Rapporto P/E:
14.08
EPS:
7.5596
Flusso di cassa netto:
$13.05B
1 W Prestazione:
+7.33%
1M Prestazione:
+6.03%
6M Prestazione:
+32.53%
1 anno Prestazione:
+7.04%
Intervallo 1D:
$105.28
$106.95
Intervallo di 1 settimana:
$98.86
$106.95
Portata 52W:
$73.31
$106.95
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
106.45 | 260.71B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,076.98 | 959.14B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
207.78 | 495.78B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
229.89 | 404.36B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
138.88 | 266.96B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-18 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Merck & Co. (MRK) Enters 2026 in the Spotlight: BMO Upgrade to $130, FDA Fast-Track Vouchers and TrumpRx Pricing Deal Reframe the Post-Keytruda Story - ts2.tech
Merck (MRK) Stock News on Dec. 25, 2025: BMO Lifts Target to $130 as FDA Fast-Track Vouchers and Keytruda Data Fuel Momentum - ts2.tech
Bar Harbor Wealth Management Buys 14,147 Shares of Merck & Co., Inc. $MRK - MarketBeat
A Tax Auditor's Secret to Building a $22 Million Fortune - The Motley Fool
Merck & Co., Inc. (NYSE:MRK) Sets New 12-Month HighWhat's Next? - MarketBeat
Vontobel Holding Ltd. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Hanson & Doremus Investment Management Lowers Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Swedbank AB Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Farther Finance Advisors LLC - MarketBeat
Merck & Co., Inc (NYSE:MRK) S&P 500 Companies Biotech Footprint - Kalkine Media
Check Out What Whales Are Doing With MRK - Benzinga
Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It? - Finviz
Yousif Capital Management LLC Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Matrix Trust Co - MarketBeat
HBK Sorce Advisory LLC Acquires 16,271 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by OFI Invest Asset Management - MarketBeat
Cliftonlarsonallen Wealth Advisors LLC Buys 13,414 Shares of Merck & Co., Inc. $MRK - MarketBeat
"Merck (MRK) is an Inexpensive Stock," Says Jim Cramer - Finviz
“Merck (MRK) is an Inexpensive Stock,” Says Jim Cramer - Yahoo Finance
Brighton Jones LLC Buys 20,086 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Position Lessened by Baldwin Wealth Partners LLC MA - MarketBeat
Merck (MRK) Stock: What to Know Before the Market Opens on Dec. 22, 2025 - ts2.tech
Lineweaver Wealth Advisors LLC Has $3.18 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Viking Fund Management LLC Purchases 19,000 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fluent Financial LLC Buys New Holdings in Merck & Co., Inc. $MRK - MarketBeat
Foster Victor Wealth Advisors LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Douglas Lane & Associates LLC Has $45.27 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans - Business Wire
Rahway-Based Merck & Co., Inc. Recognized at 46th Annual Edison Patent Awards - TAPinto
Voya Investment Management LLC Has $57.55 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Perpetual Ltd - MarketBeat
Secure Asset Management LLC Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Cyndeo Wealth Partners LLC Has $10.11 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
Merck (MRK) Stock After Hours on Dec. 19, 2025: Trump Drug-Pricing Deal, FDA Fast-Track Vouchers, and What to Watch Before Markets Reopen - ts2.tech
Top Research Reports for NVIDIA, Netflix & Merck - TradingView — Track All Markets
US FDA grants priority vouchers to Merck's cholesterol pill, cancer therapy - Reuters
Patient deaths prompt halt in Merck-Daiichi phase III in lung cancer - BioWorld MedTech
Better Buy in 2026: Pfizer or Merck? - Finviz
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
Merck (MRK) Stock News and Forecasts for Dec. 19, 2025: Drug-Pricing Deals, FDA Fast-Track Catalysts, and Wall Street Targets - ts2.tech
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Benzinga
Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center - CSRwire
Merck (MRK)'s CEO Has a "Better Hand," Says Jim Cramer - Finviz
Merck (MRK)’s CEO Has a “Better Hand,” Says Jim Cramer - Insider Monkey
Trump to announce new deals to lower drug prices, White House says - Reuters
Merck & Co., Inc. $MRK Stock Holdings Boosted by Talbot Financial LLC - MarketBeat
Merck & Co., Inc. : Technically solid - marketscreener.com
Merck's Deep Pipeline And Cash Flow Strength Support The Bull Case - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.6% Following Analyst Upgrade - MarketBeat
Merck & Company, Inc. (MRK) Stock News and Forecasts: FDA Fast-Track Signals, BMO Upgrade, and a New Keytruda–Padcev Win (Dec. 18, 2025) - ts2.tech
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.18%
1.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):